Form 4: GE HealthCare CFO James Saccaro Disposes of Shares for Tax Obligations

Sentiment:

Insider Transaction Report


GE HealthCare Technologies Inc.'s Chief Financial Officer, James Saccaro, disposed of 9,712 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

  • James Saccaro, Chief Financial Officer of GE HealthCare Technologies Inc. (GEHC), reported a transaction on June 1, 2025.
  • The transaction involved the disposition of 9,712 shares of GE HealthCare Technologies Inc. common stock.
  • The shares were disposed of at a price of $70.54 per share.
  • This disposition was identified as a withholding of shares to satisfy tax withholding obligations in connection with the vesting of restricted stock units (RSUs).
  • Following this transaction, Mr. Saccaro beneficially owns 61,832 shares of GE HealthCare Technologies Inc. common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is a neutral event and does not indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a routine insider transaction, specifically the withholding of shares by a corporate officer to cover tax liabilities associated with the vesting of restricted stock units. This is a common practice in executive compensation across various industries and does not inherently reflect on broader industry trends or competitive dynamics.

Comparison to Industry Standards

  • The practice of withholding shares to cover tax obligations upon the vesting of restricted stock units is a standard and widely accepted method of managing executive compensation and tax liabilities across publicly traded companies, including those in the healthcare technology sector.

Stakeholder Impact

  • Shareholders: The transaction is a routine part of executive compensation and tax management, with minimal direct impact on the broader shareholder base or company operations.
  • Employees: No direct impact on general employees is indicated by this filing.

Key Dates

DateDescription
06/01/2025Date of transaction (disposition of shares).
06/03/2025Date the Form 4 was signed and filed.

Keywords

GE HealthCare Technologies, GEHC, Form 4, Insider Transaction, James Saccaro, CFO, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.